Using multivariate regression model with least absolute shrinkage and selection operator (LASSO) to predict the incidence of xerostomia after intensity-modulated radiotherapy for head and neck cancer

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Lee, Tsair Fwu ^a   Chao, Pei Ju ^b   Ting, Hui Min ^a,b   Chang, Liyun ^c   Huang, Yu Jie ^b   Wu, Jia Ming ^d   Wang, Hung Yu ^a   Horng, Mong Fong ^a   Chang, Chun Ming ^a   Lan, Jen Hong ^a,b   Huang, Ya Yu ^b   Fang, Fu Min ^b   Leung, Stephen Wan ^e  

^a NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c I SHOU UNIVERSITY   (Taiwan)

^d E DA HOSPITAL   (Taiwan)

^e YUAN'S GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CALCULATION; CANCER STAGING; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; HEAD AND NECK CANCER; HUMAN; INCIDENCE; INTENSITY MODULATED RADIATION THERAPY; LEAST ABSOLUTE SHRINKAGE AND SELECTION OPERATOR; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION RESPONSE; SCORING SYSTEM; SMOKING; STATISTICAL MODEL; VALIDITY; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY, INTENSITY-MODULATED; XEROSTOMIA;

EID: 84896541567     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089700     Document Type: Article

References (42)

1. Lim C, Tassone C, Liu X, Thometz J, Lyon R (2012) Correlation of idiopathic scoliosis assessments between newly developed milwaukee topographic scanner and Quantec. Stud health technol inform 176: 255.
2. Moiseenko V, Wu J, Hovan A, Saleh Z, Apte A, et al. (2012) Treatment planning constraints to avoid xerostomia in head-and-neck radiotherapy: an independent test of QUANTEC criteria using a prospectively collected dataset. Int J Radiat Oncol Biol Phys 82: 1108-1114.
3. Beetz I, Schilstra C, Burlage FR, Koken PW, Doornaert P, et al. (2012) Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: The role of dosimetric and clinical factors. Radiother Oncol 105: 86-93.
4. Beetz I, Schilstra C, van der Schaaf A, van den Heuvel ER, Doornaert P, et al. (2012) NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: The role of dosimetric and clinical factors. Radiother Oncol 105: 101-106.
5. Beetz I, Schilstra C, van Luijk P, Christianen ME, Doornaert P, et al. (2012) External validation of three dimensional conformal radiotherapy based NTCP models for patient-rated xerostomia and sticky saliva among patients treated with intensity modulated radiotherapy. Radiother Oncol 105: 94-100.
6. Lee T-F, Fang F-M (2013) Quantitative analysis of normal tissue effects in the clinic (QUANTEC) guideline validation using quality of life questionnaire datasets for parotid gland constraints to avoid causing xerostomia during headand- neck radiotherapy. Radiother Oncol 106: 352-358.
7. El Naqa I, Bradley J, Blanco AI, Lindsay PE, Vicic M, et al. (2006) Multivariable modeling of radiotherapy outcomes, including dose-volume and clinical factors. Int J Radiat Oncol Biol Phys 64: 1275-1286.
8. van de Water TA, Bijl HP, Westerlaan HE, Langendijk JA (2009) Delineation guidelines for organs at risk involved in radiation-induced salivary dysfunction and xerostomia. Radiother Oncol 93: 545-552.
9. Xu C-J, van der Schaaf A, Schilstra C, Langendijk JA, van't Veld AA (2012) Impact of statistical learning methods on the predictive power of multivariate normal tissue complication probability models. Int J Radiat Oncol Biol Phys 82: e677-e684.
10. Xu C-J, van der Schaaf A, Van't Veld AA, Langendijk JA, Schilstra C (2012) Statistical validation of normal tissue complication probability models. Int J Radiat Oncol Biol Phys 84: e123-e129.
11. Xu J, Yin J (2013) Kernel least absolute shrinkage and selection operator regression classifier for pattern classification. Comput Vis, IET 7: 48-55.
12. Colombani C, Legarra A, Fritz S, Guillaume F, Croiseau P, et al. (2012) Application of Bayesian least absolute shrinkage and selection operator (LASSO) and BayesCp methods for genomic selection in French Holstein and Montbéliarde breeds. J Dairy Sci 96: 575-591.
13. Ogutu JO, Schulz-Streeck T, Piepho H-P (2012) Genomic selection using regularized linear regression models: ridge regression, lasso, elastic net and their extensions. BMC proceedings: BioMed Central Ltd. pp. S10.
14. Rasmussen MA, Bro R (2012) A tutorial on the Lasso approach to sparse modeling. Chemometr Intell Lab.
15. Teppola P, Taavitsainen V-M (2013) Parsimonious and robust multivariate calibration with rational function Least Absolute Shrinkage and Selection Operator and rational function Elastic Net. Analytica Chimica Acta 768: 57-68.
16. Stock JH, Watson MW (2012) Generalized shrinkage methods for forecasting using many predictors. J Bus Econ Stat 30: 481-493.
17. Chen W-C, Hwang T-Z, Wang W-H, Lu C-H, Chen C-C, et al. (2009) Comparison between conventional and intensity-modulated post-operative radiotherapy for stage III and IV oral cavity cancer in terms of treatment results and toxicity. Oral oncol 45: 505-510.
18. Lee T-F, Ting H-M, Chao P-J, Fang F-M (2012) Dual Arc volumetricmodulated Arc radiotherapy (VMAT) of nasopharyngeal carcinomas: a simultaneous integrated boost treatment plan comparison with intensitymodulated radiotherapies and single arc VMAT. Clini Oncol 24: 196-207.
19. Leung SW, Lee T-F (2013) Treatment of nasopharyngeal carcinoma by tomotherapy: five-year experience. BMC Cancer 5: 9, 1-9.
20. Bjordal K, Hammerlid E, Ahlner-Elmqvist M, de Graeff A, Boysen M, et al. (1999) Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clini Oncol 17: 1008-1008.
21. Fang F-M, Tsai W-L, Lee T-F, Liao K-C, Chen H-C, et al. (2010) Multivariate analysis of quality of life outcome for nasopharyngeal carcinoma patients after treatment. Radiother Oncol 97: 263-269.
22. Tibshirani R (1996) Regression shrinkage and selection via the lasso. J Roy Stat Soc B 267-288.
23. Hastie T, Tibshirani R, Friedman J, Franklin J (2005) The elements of statistical learning: data mining, inference and prediction. The Math Intellg 27: 83-85.
24. Skwarchuk MW, Jackson A, Zelefsky MJ, Venkatraman ES, Cowen DM, et al. (2000) Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys 47: 103-113. (Pubitemid 30179683)
25. Deasy JO, Moiseenko V, Marks L, Chao K, Nam J, et al. (2010) Radiotherapy dose-volume effects on salivary gland function. Int J Radiat Oncol Biol Phys 76: S58-S63.
26. Beetz I, Steenbakkers RJ, Chouvalova O, Leemans CR, Doornaert P, et al. (2013) The QUANTEC criteria for parotid gland dose and their efficacy to prevent moderate to severe patient-rated xerostomia. Acta Oncologica: 1-8.
27. Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, et al. (2011) Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 12: 127-136.
28. Eisbruch A, Kim HM, Terrell JE, Marsh LH, Dawson LA, et al. (2001) Xerostomia and its predictors following parotid-sparing irradiation of head-andneck cancer. Int J Radiat Oncol Biol Phys 50: 695-704. (Pubitemid 32515326)
29. Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA (1999) Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 45: 577-587. (Pubitemid 29462636)
30. Graff P, Lapeyre M, Desandes E, Ortholan C, Bensadoun R-J, et al. (2007) Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys 67: 1309-1317. (Pubitemid 46467154)
31. Kwong DL, Pow EH, Sham JS, McMillan AS, Leung LH, et al. (2004) Intensitymodulated radiotherapy for early-stage nasopharyngeal carcinoma. Cancer 101: 1584-1593.
32. Hsiung C-Y, Ting H-M, Huang H-Y, Lee C-H, Huang E-Y, et al. (2006) Parotid-sparing intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma: preserved parotid function after IMRT on quantitative salivary scintigraphy, and comparison with historical data after conventional radiotherapy. Int J Radiat Oncol Biol Phys 66: 454-461. (Pubitemid 44349039)
33. Tribius S, Sommer J, Prosch C, Bajrovic A, Muenscher A, et al. (2013) Xerostomia after radiotherapy: What matters-mean total dose or dose to each parotid gland? Strahlenther Onkol 189: 216-222.
34. Leal SC, Bittar J, Portugal A, Falcao DP, Faber J, et al. (2010) Medication in elderly people: its influence on salivary pattern, signs and symptoms of dry mouth. Gerodontology 27: 129-133.
35. Fortin I, Fortin B, Lambert L, Clavel S, Alizadeh M, et al. (2013) Xerostomia in patients treated for oropharyngeal carcinoma: Comparing LINAC-based intensity-modulated radiation therapy to helical tomotherapy. Head Neck-J Sci Spec.
36. Sturgis EM, Cinciripini PM (2007) Trends in head and neck cancer incidence in relation to smoking prevalence. Cancer 110: 1429-1435.
37. Sturgis EM, Wei Q, Spitz MR (2004) Descriptive epidemiology and risk factors for head and neck cancer. Semi Oncol 31: 726-733. (Pubitemid 39602678)
38. Rad M, Chamani G, Shahravan A, Hedayati N, Alizadeh F (2013) Survey of prevalence of xerostomia in a population of Kerman, Iran, attending medical and dental clinics. j oral health & oral epidemiology 2: 28-34.
39. van der Schaaf A, Xu C-J, van Luijk P, van't Veld AA, Langendijk JA, et al. (2012) Multivariate modeling of complications with data driven variable selection: Guarding against overfitting and effects of data set size. Radiother Oncol 105: 115-121.
40. Henson B, Inglehart M, Eisbruch A, Ship J (2001) Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy. Oral oncol 37: 84-93.
41. Kaneko M, Shirato H, Nishioka T, Ohmori K, Takinami S, et al. (1998) Scintigraphic evaluation of long-term salivary function after bilateral whole parotid gland irradiation in radiotherapy for head and neck tumour. Oral oncol 34: 140-146. (Pubitemid 28207015)
42. Franzén L, Funegard U, Ericson T, Henriksson R (1992) Parotid gland function during and following radiotherapy of malignancies in the head and neck: a consecutive study of salivary flow and patient discomfort. Europ J Cancer 28: 457-462.